Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia. (Q36536184)
Jump to navigation
Jump to search
scientific article published on January 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia. |
scientific article published on January 2007 |
Statements
Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia (English)
Man-Chiu Poon
1 January 2007
5 references
6 March 2019
22 April 2019
28 September 2019
27 November 2019
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference